Auctus Advisors’s Colgate-Palmolive CL Stock Holding History

Auctus Advisors’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$917K	Hold	10,000	–	–	0.77%	7
2026 Q1	$852K	Hold	10,000	–	–	0.81%	8
2025 Q4	$790K	Buy	+10,000	New	+$784K	0.73%	7

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Auctus Advisors's CL Position: Q2 2026 in Review

Auctus Advisors held its Colgate-Palmolive (CL) position steady in Q2 2026 at 10,000 shares worth $917K. The position accounts for 0.77% of the portfolio, ranked #7.

Auctus Advisors first reported a position in CL in Q4 2025 and has held it in 3 quarters since. 2,003 funds tracked by Wall St. Rank hold CL as of Q2 2026.

Auctus Advisors held 10,000 shares of Colgate-Palmolive worth $917K as of Q2 2026.
Auctus Advisors left its Colgate-Palmolive share count unchanged in Q2 2026.
Colgate-Palmolive made up 0.77% of Auctus Advisors's portfolio in Q2 2026, its #7 holding.
Auctus Advisors first reported a position in Colgate-Palmolive in Q4 2025 and has held it in 3 quarters since.
2,003 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Auctus Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.